Differential effects of environmental chemicals and food contaminants on adipogenesis, biomarker release and PPARγ activation

Molecular and Cellular Endocrinology

Volumn 361, Issue 1-2, 2012, Pages 106-115

  Taxvig, Camilla ^a   Dreisig, Karin ^a   Boberg, Julie ^a   Nellemann, Christine ^a   Schelde, Ane Blicher ^a   Pedersen, Dorthe ^a   Boergesen, Michael ^b   Mandrup, Susanne ^b   Vinggaard, Anne Marie ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

3T3 L1 cells; Adipogenesis; Adiponectin; Endocrine disrupting chemicals; Leptin; PPAR

Indexed keywords

1,2 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; 2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 4,4' ISOPROPYLIDENEDIPHENOL; ADIPONECTIN; BIOLOGICAL MARKER; BUTYL PARABEN; CHLORPYRIFOS; DELTAMETHRIN; LEPTIN; MANCOZEB; MONOETHYLHEXYL PHTHALATE; PERFLUOROOCTANOIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHTHALIC ACID ESTER; POLYCHLORINATED BIPHENYL 153; POLYCHLORINATED BIPHENYL DERIVATIVE; PROCHLORAZ; RESISTIN; ROSIGLITAZONE; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; ARTICLE; CELL DIFFERENTIATION; CELL STIMULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FOOD CONTAMINATION; HORMONE RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN SECRETION;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; ENVIRONMENTAL POLLUTANTS; FOOD CONTAMINATION; LEPTIN; LIPID METABOLISM; MICE; PPAR ALPHA; PPAR GAMMA; RESISTIN; STAINING AND LABELING;

EID: 84864327615     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.03.021     Document Type: Article

References (52)

1. Argiles J.M., Lopez-Soriano J., Busquets S., Lopez-Soriano F.J. Journey from cachexia to obesity by TNF. Faseb Journal 1997, 11:743-751.
2. Arsenescu V., Arsenescu R.I., King V., Swanson H., Cassis L.A. Polychlorinated biphenyl-77 induces adipocyte differentiation and proinflammatory adipokines and promotes obesity and atherosclerosis. Environmental Health Perspectives 2008, 116:761-768.
3. Baillie-Hamilton P.F. Chemical toxins: a hypothesis to explain the global obesity epidemic. Journal of Alternative and Complementary Medicine 2002, 8:185-192.
4. Bility M.T., Thompson J.T., McKee R.H., David R.M., Butala J.H., Vanden Heuvel J.P., Peters J.M. Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters. Toxicological Sciences 2004, 82:170-182.
5. Boberg J., Metzdorff S., Wortziger R., Axelstad M., Brokken L., Vinggaard A.M., Dalgaard M., Nellemann C. Impact of diisobutyl phthalate and other PPAR agonists on steroidogenesis and plasma insulin and leptin levels in fetal rats. Toxicology 2008, 250:75-81.
6. Casals-Casas C., Desvergne B. Endocrine disruptors: from endocrine to metabolic disruption. Annual Review of Physiology 2011, 73:135-162.
7. Casals-Casas C., Feige J.N., Desvergne B. Interference of pollutants with PPARs: endocrine disruption meets metabolism. International Journal of Obesity (Lond) 2008, 32(Suppl 6):S53-S61.
8. Djiane J., Attig L. Role of leptin during perinatal metabolic programming and obesity. Journal of Physiology and Pharmacology 2008, 59(Suppl 1):55-63.
9. Dreyer C., Krey G., Keller H., Givel F., Helftenbein G., Wahli W. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell 1992, 68:879-887.
10. Eric, H., Nira, B.-J., 2011. Endocrine Disruptors, Adipokines and the Metabolic Syndrome, Adipokines. Science Publishers, pp. 228-242.
11. Feige J.N., Gelman L., Rossi D., Zoete V., Metivier R., Tudor C., Anghel S.I., Grosdidier A., Lathion C., Engelborghs Y., Michielin O., Wahli W., Desvergne B. The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor gamma modulator that promotes adipogenesis. Journal of Biological Chemistry 2007, 282:19152-19166.
12. Ferre P. The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes 2004, 53(Suppl 1):S43-S50.
13. Frontera M., Dickins B., Plagge A., Kelsey G. Imprinted genes, postnatal adaptations and enduring effects on energy homeostasis. Advances in Experimental Medicine and Biology 2008, 626:41-61.
14. Gimeno R.E., Klaman L.D. Adipose tissue as an active endocrine organ: recent advances. Current Opinion in Pharmacology 2005, 5:122-128.
15. Green H., Meuth M. An established pre-adipose cell line and its differentiation in culture. Cell 1974, 3:127-133.
16. Gregoire F.M., Smas C.M., Sul H.S. Understanding adipocyte differentiation. Physiological Reviews 1998, 78:783-809.
17. Grun F., Blumberg B. Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis. Review of Endocrin Metabolic Disorders 2007, 8:161-171.
18. Grun F., Blumberg B. Endocrine disrupters as obesogens. Molecular and Cellular Endocrinology 2009, 304:19-29.
19. Grun F., Blumberg B. Minireview: the case for obesogens. Molecular Endocrinology 2009, 23:1127-1134.
20. Harvey P.W., Darbre P. Endocrine disrupters and human health: could oestrogenic chemicals in body care cosmetics adversely affect breast cancer incidence in women?. Journal of Applied Toxicology 2004, 24:167-176.
21. Hass U., Scholze M., Christiansen S., Dalgaard M., Vinggaard A.M., Axelstad M., Metzdorff S.B., Kortenkamp A. Combined exposure to anti-androgens exacerbates disruption of sexual differentiation in the rat. Environmental Health Perspectives 2007, 115(Suppl 1):122-128.
22. Heindel J.J. Endocrine disruptors and the obesity epidemic. Toxicological Sciences 2003, 76:247-249.
23. Hurst C.H., Waxman D.J. Activation of PPARalpha and PPARgamma by environmental phthalate monoesters. Toxicological Sciences 2003, 74:297-308.
24. Kallen C.B., Lazar M.A. Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes. Proceedings of National Academic Science, USA 1996, 93:5793-5796.
25. Kershaw E.E., Flier J.S. Adipose tissue as an endocrine organ. Journal of Clinical Endocrinology and Metabolism 2004, 89:2548-2556.
26. Kim K.H., Lee K., Moon Y.S., Sul H.S. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. Journal of Biological Chemistry 2001, 276:11252-11256.
27. Kortenkamp, A., Backhaus, T., Faust, M., 2009. State of the Art Report on Mixture Toxicity. Final Report, Executive Summary, pp. 1-391.
28. Kubota N., Yamauchi T., Tobe K., Kadowaki T. Adiponectin-dependent and -independent pathways in insulin-sensitizing and antidiabetic actions of thiazolidinediones. Diabetes 2006, 55:S32-S38.
29. Lampen A., Zimnik S., Nau H. Teratogenic phthalate esters and metabolites activate the nuclear receptors PPARs and induce differentiation of F9 cells. Toxicology and Applied Pharmacology 2003, 188:14-23.
30. Langer P., Kocan A., Tajtakova M., Petrik J., Chovancova J., Drobna B., Jursa S., Radikova Z., Koska J., Ksinantova L., Huckova M., Imrich R., Wimmerova S., Gasperikova D., Shishiba Y., Trnovec T., Sebokova E., Klimes I. Fish from industrially polluted freshwater as the main source of organochlorinated pollutants and increased frequency of thyroid disorders and dysglycemia. Chemosphere 2007, 67:S379-S385.
31. Levin B.E. Metabolic imprinting: critical impact of the perinatal environment on the regulation of energy homeostasis. Philosophical Transactions of the Royal Society of London Series B - Biological Sciences 2006, 361:1107-1121.
32. Maloney E.K., Waxman D.J. Trans-activation of PPARalpha and PPARgamma by structurally diverse environmental chemicals. Toxicology and Applied Pharmacology 1999, 161:209-218.
33. Mantzoros C.S., Rifas-Shiman S.L., Williams C.J., Fargnoli J.L., Kelesidis T., Gillman M.W. Cord blood leptin and adiponectin as predictors of adiposity in children at 3years of age: a prospective cohort study. Pediatrics 2009, 123:682-689.
34. Miyawaki J., Sakayama K., Kato H., Yamamoto H., Masuno H. Perinatal and postnatal exposure to bisphenol a increases adipose tissue mass and serum cholesterol level in mice. Journal of Atherosclerosis and Thrombosis 2007, 14:245-252.
35. Muxlow A.M., Fowles S., Russell P. Automated high-performance liquid chromatography method for the determination of rosiglitazone in human plasma. Journal of Chromatography B: Biomedical Sciences and Applications 2001, 752:77-84.
36. Newbold R.R., Padilla-Banks E., Jefferson W.N., Heindel J.J. Effects of endocrine disruptors on obesity. International Journal of Andrology 2008, 31:201-208.
37. Patel N.G., Holder J.C., Smith S.A., Kumar S., Eggo M.C. Differential regulation of lipogenesis and leptin production by independent signaling pathways and rosiglitazone during human adipocyte differentiation. Diabetes 2003, 52:43-50.
38. Phrakonkham P., Viengchareun S., Belloir C., Lombes M., Artur Y., Canivenc-Lavier M.C. Dietary xenoestrogens differentially impair 3T3-L1 preadipocyte differentiation and persistently affect leptin synthesis. Journal of Steroid Biochemistry Biology and Biotechnology 2008, 110:95-103.
39. Rider C.V., Furr J., Wilson V.S., Gray L.E. A mixture of seven antiandrogens induces reproductive malformations in rats. International Journal of Andrology 2008, 31:249-262.
40. Smink A., Ribas-Fito N., Garcia R., Torrent M., Mendez M.A., Grimalt J.O., Sunyer J. Exposure to hexachlorobenzene during pregnancy increases the risk of overweight in children aged 6years. Acta Paediatrica 2008, 97:1465-1469.
41. Spiegelman B.M., Flier J.S. Adipogenesis and obesity: rounding out the big picture. Cell 1996, 87:377-389.
42. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., Patel H.R., Ahima R.S., Lazar M.A. The hormone resistin links obesity to diabetes. Nature 2001, 409:307-312.
43. Swedenborg E., Ruegg J., Makela S., Pongratz I. Endocrine disruptive chemicals: mechanisms of action and involvement in metabolic disorders. Journal of Molecular Endocrinology 2009, 43:1-10.
44. Tang Q.Q., Otto T.C., Lane M.D. Mitotic clonal expansion: a synchronous process required for adipogenesis. Proceedings of National Academic Science, USA 2003, 100:44-49.
45. Tontonoz P., Hu E., Spiegelman B.M. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 1994, 79:1147-1156.
46. Tontonoz P., Spiegelman B.M. Fat and beyond: the diverse biology of PPARgamma. Annual Review of Biochemistry 2008, 77:289-312.
47. Ukkola O., Santaniemi M. Adiponectin: a link between excess adiposity and associated comorbidities?. Journal of Molecular Medicine 2002, 80:696-702.
48. Vasiliu O., Cameron L., Gardiner J., Deguire P., Karmaus W. Polybrominated biphenyls, polychlorinated biphenyls, body weight, and incidence of adult-onset diabetes mellitus. Epidemiology 2006, 17:352-359.
49. Vickers M.H. Developmental programming and adult obesity: the role of leptin. Current Opinion in Endocrinology, Diabetes and Obesity 2007, 14:17-22. 10.1097/MED.1090b1013e328013da328048.
50. vom Saal, F.S., Nagel, S.C., Coe, B.L., Angle, B.M., Taylor, J.A., 2012. The estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesity. Molecular and Cellular Endocrinology.
51. Wang S.-L., Tsai P.-C., Yang C.-Y., Leon Guo Y. Increased risk of diabetes and polychlorinated biphenyls and dioxins. Diabetes Care 2008, 31:1574-1579.
52. Zeigerer A., Rodeheffer M.S., McGraw T.E., Friedman J.M. Insulin regulates leptin secretion from 3T3-L1 adipocytes by a PI 3 kinase independent mechanism. Experimental Cell Research 2008, 314:2249-2256.